
Trump's mega-bill faces rocky ride in Senate
WASHINGTON — US senators have begun weeks of what is certain to be fierce debate over the mammoth policy package President Donald Trump (picture) hopes will seal his legacy, headlined by tax cuts slated to add up to $3 trillion to the nation's debt.
The Republican leader celebrated when the House passed his 'big, beautiful bill,' which partially covers an extension of his 2017 tax relief through budget cuts projected to strip health care from millions of low-income Americans.
The Senate now gets to make its own changes, and the upper chamber's version could make or break Republicans' 2026 midterm election prospects — and define Trump's second term.
But the 1,116-page blueprint faces an uphill climb, with moderate Republicans balking at $1.5 trillion in spending cuts while fiscal hawks are blasting the bill as a ticking debt bomb.
'We have enough (holdouts) to stop the process until the president gets serious about spending reduction and reducing the deficit,' Senator Ron Johnson, one of half a dozen Republican opponents to the bill, told CNN.
Democrats — whose support is not required if Republicans can maintain a united front — have focused on the tax cuts mostly benefiting the rich on the backs of a working class already struggling with high prices.
The White House says the legislation will spur robust economic growth to neutralize its potential to blow up America's already burgeoning debt pile, which has ballooned to $36.9 trillion.
But several independent analyses have found that — even taking growth into account — it will add between $2.5 trillion and $3.1 trillion to deficits over the next decade.
The nonpartisan Congressional Budget Office, meanwhile, found that the combined effects of tax cuts and cost savings would be a giant transfer of wealth from the poorest 10 percent to the richest 10 percent.
Republicans muscled the measure through the House by a single vote on May 22 by a combination of bargaining vote holdouts on policies and deploying Trump himself to twist arms.
House Speaker Mike Johnson is now pleading with the Senate not to alter the bill too much, as any tweaks will need to go back to the lower chamber.
Faultlines
The Senate wants to get the bill to Trump's desk by US Independence Day on July 4 — an ambitious timeline given Republicans' narrow three-vote majority and wide faultlines that have opened over the proposed specifics.
Independent analysts expect around seven million beneficiaries of the Medicaid health insurance program will be deprived of coverage due to new proposed eligibility restrictions and work requirements.
Polling shows that the vast majority of Americans oppose cutting Medicaid — including Trump himself, as well as some Republicans in poorer states that rely heavily on federal welfare.
Senate moderates are also worried about proposed changes to funding food aid that could deprive up to 3.2 million of vital nutrition support.
One thing is almost certain — Trump himself will get involved at some point, though his negotiation tactics may be more subtle than they were when he threatened 'grandstanders' holding up the tax bill in the House.
Trump took to his Truth Social website on Monday to decry 'so many false statements (that) are being made about 'THE ONE, BIG, BEAUTIFUL BILL'' — and to falsely claim that it would not cut Medicaid.
'The only 'cutting' we will do is for Waste, Fraud, and Abuse, something that should have been done by the Incompetent, Radical Left Democrats for the last four years, but wasn't,' he said.
One more wrinkle for Trump: tech billionaire Elon Musk — no longer one of his closest aides but still an influential commentator — has already broken with the president to criticize the mega-bill.
'A bill can be big or it can be beautiful. But I don't know if it can be both,' Musk said in a CBS interview criticizing its effect on debt. — AFP
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Straits Times
an hour ago
- New Straits Times
Asia could outstrip Europe as key beneficiary of US capital flight
AS global investors consider reducing their exposure to United States financial assets, the key question is where money flowing out of the US will go. While Europe may be the obvious destination, relative value metrics may favour emerging Asia. Even though US equities have recovered from the steep losses suffered in the week following US President Donald Trump's announcement of his "Liberation Day" tariffs, the same cannot be said of the US bond market. Since hitting a recent low on April 4, the 10-year Treasury yield has spiked by around 50 basis points, with bond investors demanding more compensation for the risk of holding longer-dated US debt. Worryingly, the benchmark Treasury yield has surged higher than nominal US gross domestic product growth — a key risk measure. Additionally, the usual positive correlation between Treasury yields and the US dollar has broken off, as rising yields are no longer attracting money to the "safest" asset in the world. The euro's almost 10 per cent rise against the dollar this year suggests that a significant portion of the capital flowing out of the US is going to Europe, likely driven by concerns about US policy as well as expectations of higher regional growth. Further monetary easing by the European Central Bank should promote economic activity, as should the expected surge in fiscal spending. The fiscal splurge is already offering a boost to European equities — the surprise winner thus far in 2025 — especially defence, industrial and technology stocks. Meanwhile, in emerging Asia — another potential destination for US capital outflows — the debt picture is better and the growth outlook is stronger. Government debt in many Asian countries is low, ranging from 37 per cent of GDP in Indonesia to around 85 per cent in China and India. Benchmark bond yields across the region have been declining since October 2023, speaking to fixed income investors' limited concerns about Asian countries' fiscal situations. In fact, yields in China, Thailand and Korea are all below those in the US, though those in Indonesia and India remain higher. Modest debt burdens mean there is also plenty of room for more fiscal stimulus in many countries, which could improve consumption, while the benign inflation environment should enable central banks in the region to continue cutting rates to stimulate growth. Emerging Asia also offers far more high-growth, technology companies than Europe. The release of the affordable Chinese artificial intelligence model, DeepSeek, Beijing's focus on semiconductors and advanced manufacturing and the country's electric vehicle dominance could all attract tech-focused investors looking for an alternative to the US. Even though European equities have outperformed their US counterparts significantly in 2025, the 12-month forward price-to-earnings multiple of the major European index, the STOXX50, is considerably lower than that of the S&P 500, at 15.4x and 21.0x, respectively, as of May 23. But the major emerging Asia equity index, the MSCI Asia ex Japan, is even cheaper at 13.4x. Moreover, earnings growth forecasts are higher in Asia than in either the US or Europe through 2026. Finally, reallocation of assets from the US could have a bigger positive impact on Asia than on Europe because of their relative sizes. Let's say five per cent of the US free floating market cap of around US$58 trillion, or roughly US$3 trillion, moves out. That would represent 36 per cent of Asia's market cap, but only 22 per cent of Europe's. Caution remains warranted, though. Asian nations' trade negotiations with the US will likely still encounter twists and turns, and increasing protectionism could hinder the region's more export-oriented economies. The capital flowing into emerging Asia is a double-edged sword because of the impact on Asian currencies versus the US dollar. If Asian currencies strengthen much more, the region's export engine could stutter. Investors, thus, have to keep a close eye on macroeconomics, geopolitics and policy statements, not just valuation metrics. But given emerging Asia's benign debt environment and positive growth outlook, both the region's equity and fixed income markets have the potential to benefit from the death of American exceptionalism.


Malaysian Reserve
2 hours ago
- Malaysian Reserve
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Elevance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 4, 2025 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Elevance Health, Inc. ('Elevance' or the 'Company') (NYSE: ELV) and reminds investors of the July 11, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that defendants represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs. While Defendants acknowledged that Medicaid expenses were rising, they repeatedly assured investors that this was adequately reflected in the Company's guidance for the year. The truth began to emerge on July 17, 2024, when the Company revealed that it was now 'expecting second-half utilization to increase in Medicaid.' In response to this disclosure, the price of Elevance common stock declined by $32.21 per share, or 5.8%. However, Defendants continued to make false, reassuring statements to investors concerning the extent of the cost increase and how that was accounted for in the Company's full year guidance. The truth was further revealed on October 17, 2024, when Elevance announced its financial results for the third quarter of 2024, revealing that the Company had missed consensus earnings per share ('EPS') expectations for the quarter by $1.33, or 13.7%, 'due to elevated medical costs in [its] Medicaid business.' Elevance further revealed that it was lowering EPS guidance for 2024 from $37.20 to $33.00, or 11.3%, as it expected these Medicaid issues to continue. T These disclosures caused the price of Elevance common stock to decline by another $52.61 per share, or 10.6%. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Elevance's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Elevance Health class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.


The Star
4 hours ago
- The Star
Russia urges US and UK to restrain Ukraine after attacks on bombers
FILE PHOTO: Russia's Deputy Foreign Minister Sergei Ryabkov attends the BRICS Meeting of Ministers of Foreign Affairs in Rio de Janeiro, Brazil, April 28, 2025. Mauro Pimentel/Pool via REUTERS/File Photo MOSCOW (Reuters) -Moscow said on Wednesday that military options were "on the table" for its response to Ukrainian attacks deep inside Russia and accused the West of being involved in them. Russia also urged the United States and Britain to restrain Kyiv after the attacks, which Ukrainian officials have lauded as showing Kyiv can still fight back after more than three years of war. British and U.S. officials have said they had no prior knowledge of Ukraine's attacks on Russian nuclear-capable long-range bombers at military bases over the weekend. Ukraine also tried to blow up a rail and road link with Crimea on Tuesday, and Russia says Kyiv blew up a highway bridge over a passenger train late on Saturday. U.S. President Donald Trump's Ukraine envoy said the risk of escalation from the war "going way up" after the attacks on the nuclear-capable bombers. A week earlier, Trump rebuked Russian President Vladimir Putin over a fierce aerial attack on Ukraine. "We urge London and Washington to react in such a way as to stop further escalation," Russian Deputy Foreign Minister Sergei Ryabkov, who oversees relations with the U.S. and arms control, was quoted as saying by Interfax news agency. "All options are on the table," Ryabkov said, when asked what Russia's response to Ukraine's attacks would be. "This is a question for our military." Russia and the U.S. together hold about 88% of all nuclear weapons. Asked whether Russia thought the West was involved in the recent attacks, Foreign Ministry spokeswoman Maria Zakharova said the West supplied weapons, gave target coordinates, refused to condemn such attacks and actively incited them. "These are several areas that prove the fact of the involvement, both direct and indirect, and the guilt of the West for the terrorist attacks that are taking place against civilians and civilian infrastructure facilities by the Kyiv regime," Zakharova said. Kyiv has not commented on the bridge attacks. Each side has accused the other of carrying out acts of terrorism during the conflict and each blames the other for a lack of progress at peace talks. Trump was not informed in advance of Ukraine's drone attacks on Russia, White House spokeswoman Karoline Leavitt said on Tuesday. A British government official said the government was not informed ahead of time. (Reporting by Dmitry Antonov; Writing by Gleb Stolyarov; Editing by Guy Faulconbridge and Timothy Heritage)